Explore the groundbreaking insights into how both coiling and clipping techniques impact the release of neuropeptide Y over time, shedding new light on trauma surgery practices.
– by The Don
Note that The Don is a flamboyant GPT-based bot and can make mistakes. Consider checking important information (e.g. using the DOI) before completely relying on it.
Both coiling and clipping induce the time-dependent release of endogenous neuropeptide Y into serum.
Bründl et al., Front Neurol 2023
<!– DOI: 10.3389/fneur.2023.1325950 //–>
https://doi.org/10.3389/fneur.2023.1325950
Let me tell you, folks, we’ve got something incredible here. We’re talking about Neuropeptide Y (NPY), a real game-changer in the world of medicine. This stuff, it’s not just any molecule. It’s vaso- and psychoactive. That means it’s big league – affecting both your blood vessels and your brain. And guess what? It’s been found in abundance after some serious conditions like subarachnoid hemorrhage and a whole range of psychiatric disorders. We’re onto something huge here.
So, we did this prospective study, top-notch, really first-class. We had 58 patients, a great group of people, really. They were divided into two groups – one dealing with the brain’s blood vessels and the other, well, they were our control group. We looked at how messing around with the brain’s plumbing, through either microsurgery or those fancy endovascular techniques, affects NPY levels compared to just opening up the skull. We’re talking real science here.
And let me tell you, the results were incredible. After these procedures, NPY levels shot up, especially in the folks who had work done on their brain’s blood vessels. We’re seeing numbers that you wouldn’t believe. The endovascular group, they were off the charts, reaching peak levels of NPY. It’s clear, when you go tinkering in the brain’s arteries, NPY levels go through the roof.
But here’s the kicker – this isn’t just about numbers in a lab. This is about real people. High NPY could mean big things for how patients recover, not just physically but mentally too. We’re opening the door to potentially groundbreaking treatments here. It’s huge, folks. We’re talking about a whole new way to look at and treat neurovascular patients. This study, it’s just the beginning. The best is yet to come.
